Marc Pellegrini is an infectious diseases physician and CEO of The Centenary Institute. He investigates host-pathogen interactions, the role of immunity and host cell death pathways in infectious diseases pathogenesis. He therapeutically targets host cell apoptosis as a potential method to eliminate pathogens including anti-microbial resistant organisms.

Dr. Marit van Gils is focused on understanding how vaccines induce protective antibodies against viral infections, including HIV and more recently, coronaviruses. She completed her Ph.D., and postdoctoral research at the University of Amsterdam and partly at Scripps Research, San Diego, USA. Her discoveries have informed next-generation HIV vaccine designs.

Andleeb Hanif is working at Kirby Institute as a PhD Scholar in an Immunovirology & Pathogenesis Program. Her work is focused on different viral models in order to dissect the mechanism of (si)RNA induced transcriptional/ Epigenetic silencing machinery in human cells with an end goal of gene therapy.

Alison Castley has been working as a scientist in the field of HIV medicine for 25 years. Over the past 10 years her goals have been to work towards improving surveillance and monitoring of immunological outcomes relevant to long term co-morbidities and drug resistant mutation in HIV infection.